Session Information
2013 Midyear Clinical Meeting
Click here to go to the previous page
Three Shades of Grey: When Common Therapeutics is Not Black or White
Track:
New Practitioners Sessions (CE)
Program Code: 316-L01
Date: Sunday, December 8, 2013
Time: 3:30 PM to 5:00 PM EST
Location:
W312 B, Level 3
PRESENTER(S):
Dr. Nicholas Leon, PharmD, BCACP, Assistant Professor, Jefferson School of Pharmacy
Bhavik Shah
Kristin Watson
PROGRAM CHAIR:
Dr. Nicholas Leon, PharmD, BCACP, Assistant Professor, Jefferson School of Pharmacy
- Recommend and defend an appropriate HbA1c goal for a patient with type 2 diabetes.
- Recommend dual antiplatelet therapy, considering patient variables, for acute coronary syndrome patients or those undergoing Percutaneous coronary intervention.
- Recommend when it is appropriate to use mono-antibiotic therapy to cover against pseudomonas.
- Summarize primary literature regarding HbA1c in type 2 diabetes, selecting P2Y12 antagonists, and double coverage for Pseudomonas.
This session is a part of: